AstraZeneca vaccine
AstraZeneca says vaccine 76% effective in updated US trial data
AstraZeneca was an early frontrunner in the global race to develop a COVID vaccine, and was heavily favored by the United States
A dozen countries suspend AstraZeneca shots over fears of blood clots
WHO has said countries should continue to use the vaccine while also set to hold an expert meeting today on the issue
Serum likely to supply COVID-19 vaccine at over Rs 250 per dose to Indian government
Poonawalla had said Serum will first focus on supplying the vaccine to Indians before distributing it to other countries
Oxford and AstraZeneca resume coronavirus vaccine trial
The university confirmed the restart across all of its UK trial sites after regulators gave the go-ahead following the pause on Sunday
1 of 1